NRI Wealth Management LC Acquires Shares of 9,185 HCA Healthcare, Inc. (NYSE:HCA)

NRI Wealth Management LC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 2nd quarter, HoldingsChannel reports. The firm bought 9,185 shares of the company’s stock, valued at approximately $2,951,000. HCA Healthcare comprises approximately 2.3% of NRI Wealth Management LC’s holdings, making the stock its 9th largest holding.

Other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of HCA Healthcare by 0.4% in the first quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock worth $5,666,569,000 after purchasing an additional 60,304 shares during the last quarter. Sanders Capital LLC lifted its holdings in HCA Healthcare by 4.2% in the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after buying an additional 456,738 shares during the period. Wellington Management Group LLP lifted its holdings in HCA Healthcare by 1.7% in the fourth quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock worth $2,757,181,000 after buying an additional 170,560 shares during the period. Royal Bank of Canada lifted its holdings in HCA Healthcare by 35.7% in the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock worth $1,219,121,000 after buying an additional 1,183,890 shares during the period. Finally, Capital World Investors lifted its holdings in HCA Healthcare by 57.5% in the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after buying an additional 1,019,750 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 2.5 %

Shares of HCA stock opened at $387.98 on Monday. HCA Healthcare, Inc. has a 1 year low of $215.96 and a 1 year high of $403.05. The firm has a fifty day moving average price of $355.43 and a 200-day moving average price of $336.01. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The company has a market cap of $100.13 billion, a price-to-earnings ratio of 19.34, a PEG ratio of 1.45 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. During the same quarter in the previous year, the firm posted $4.29 EPS. The company’s revenue for the quarter was up 10.3% compared to the same quarter last year. As a group, equities analysts predict that HCA Healthcare, Inc. will post 22.48 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.68%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s dividend payout ratio is currently 13.16%.

Wall Street Analysts Forecast Growth

HCA has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft lifted their target price on shares of HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a report on Friday, June 28th. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Royal Bank of Canada lifted their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. JPMorgan Chase & Co. boosted their price objective on shares of HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a report on Thursday, May 30th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a report on Monday, August 19th. Five investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have issued a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $359.89.

Insider Buying and Selling

In related news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now owns 17,755 shares in the company, valued at approximately $6,303,912.75. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the sale, the senior vice president now owns 9,454 shares in the company, valued at approximately $3,436,623.54. The disclosure for this sale can be found here. In the last quarter, insiders sold 8,844 shares of company stock valued at $3,185,932. Company insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.